The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction

Suzan Willemsen,Jasper W.L. Hartog,Dirk J. van Veldhuisen,Peter van der Meer,Joline F. Roze,Tiny Jaarsma,Casper G. Schalkwijk,Iwan C. C. van der Horst,Hans L. Hillege,Adriaan A. Voors

The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction

2012

Suzan Willemsen
Jasper W.L. Hartog
Dirk J. van Veldhuisen
Peter van der Meer
Joline F. Roze
Tiny Jaarsma
Casper G. Schalkwijk
Iwan C. C. van der Horst
Hans L. Hillege
Adriaan A. Voors

Introduction Advanced glycation end products (AGEs) are increased in patients with heart failure (HF). We studied the predictive value of plasma AGEs N-E-(carboxymethyl) lysine (CML), pentosidine, ...

Keywords:

Diabetes mellitus
Heart failure
Glycation
Internal medicine
Pentosidine
Ejection fraction
Cardiology
Medicine
in patient
predictive value
Receptor

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations